Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 3.11.2014 | EN | Official Journal of the European Union | C 388/12 |

---

Judgment of the General Court of 24 September 2014 — Sanofi v OHIM — GP Pharm (GEPRAL)

(Case T-493/12)[(1)](#ntr1-C_2014388EN.01001202-E0001)

((Community trade mark - Opposition proceedings - International registration designating the European Community - Word mark GEPRAL - Earlier international word mark DELPRAL - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009))

2014/C 388/14

Language of the case: English

Parties

Applicant: Sanofi SA (Paris, France) (represented by: C. Hertz-Eichenrode, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: P. Geroulakos, acting as Agent)

Other party to the proceedings before the Board of Appeal of OHIM: GP Pharm SA (Sant Quinti de Mediona, Spain)

Re:

Action brought against the decision of the Second Board of Appeal of OHIM of 5 September 2012 (Case R 201/2012-2), concerning opposition proceedings between Sanofi SA and GP Pharm SA.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Annuls the Decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 5 September 2012 (Case R 201/2012-2), concerning opposition proceedings between Sanofi SA and GP Pharm SA; |

|  |  |
| --- | --- |
| 2. | Orders OHIM to pay the costs. |

---

[Top](#document1)